Breakthrough Drug Approvals Boost Healthcare Stocks
Several pharmaceutical companies receive FDA approval for innovative treatments, driving sector performance.
Healthcare Sector
Medical and pharmaceutical
Top Healthcare Movers Today
Biggest percentage movers on the NSE Healthcare space with fresh commentary and outlook.
Sun Pharma
SUNPHARMA • NSE
₹1,745.80
+65.80
(+3.92%)
Prev Close: ₹1,680.00
52W: ₹1,050 - ₹1,800
US FDA approval for key specialty drug in dermatology segment, expected to generate $400 million in annual revenue.
Pharmaceuticals
View analysis
Divi's Laboratories
DIVISLAB • NSE
₹4,235.50
+135.50
(+3.30%)
Prev Close: ₹4,100.00
52W: ₹3,200 - ₹4,500
Record quarterly performance with EBITDA margin of 38%, driven by high-margin API exports and new custom synthesis contracts.
Pharmaceuticals - API
View analysis
Cipla
CIPLA • NSE
₹1,485.30
+40.30
(+2.79%)
Prev Close: ₹1,445.00
52W: ₹1,150 - ₹1,580
Strong growth in respiratory franchise with new combo therapy gaining market share; trade generics business in US showing recovery.
Pharmaceuticals - Respiratory
View analysis
Dr. Reddy's Labs
DRREDDY • NSE
₹6,420.75
+170.75
(+2.73%)
Prev Close: ₹6,250.00
52W: ₹4,850 - ₹6,800
Launched authorized generic for blockbuster diabetes drug in US market with 180-day exclusivity, expected to generate $150 million.
Pharmaceuticals
View analysis
Aurobindo Pharma
AUROPHARMA • NSE
₹1,345.60
+35.60
(+2.72%)
Prev Close: ₹1,310.00
52W: ₹950 - ₹1,450
Turnaround story gaining traction with US business stabilizing and European operations showing strong growth of 18%.
Pharmaceuticals - Generics
View analysis
Latest Healthcare Articles
In-depth analysis and insights for the Healthcare sector.